Tue.Jan 28, 2025

article thumbnail

As some Medicaid sites freeze up, White House acts to clarify pause on grants and programs

STAT

WASHINGTON — A new memo from the White House budget office indicates that Medicaid payments should not be affected by a pause on some federal grants. States, though, on Tuesday were reporting difficulties accessing Medicaid payment portals. “Mandatory programs like Medicaid and SNAP will continue without pause,” the White House Office of Management and Budget stated in a two-page memo sent to Capitol Hill Tuesday.

310
310
article thumbnail

Bringing drugs to market has ‘never been more challenging,’ and pharma is learning to adapt

PharmaVoice

As changes to the U.S. regulatory foundation take hold, pharmas need to change their strategies to keep innovation — and the bottom line — above the surface.

163
163
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Opinion: The most important survival skill for doctors

STAT

Earlier this month, a newer patient came in to see me for a check-up and discussion about her extremely high cholesterol level. In her late 50s with a family history of early-age heart attack, she was in a high-risk group for future stroke and coronary heart disease. When I suggested that a statin drug would help mitigate this risk, she replied with something I’m increasingly hearing from patients: “I’m really not a medicine person.

153
153
article thumbnail

FDA approves new Alzheimer’s treatment regimen

Pharma Times

Patients and care partners may find once every four weeks maintenance dosing easier

135
135
article thumbnail

Navigating Payroll Compliance: Future-Proofing Payroll in an Evolving Regulatory Landscape

Speaker: Jennifer Hill

Payroll compliance is a cornerstone of business success, yet for small and midsize businesses, it’s becoming increasingly challenging to navigate the ever-evolving landscape of federal, state, and local regulations. Mistakes can lead to costly penalties and operational disruptions, making it essential to adopt advanced solutions that ensure accuracy and efficiency.

article thumbnail

Atalanta banks $97M to send RNAi drugs into the brain

BioPharma Dive

The startup says its specially constructed RNAi therapies can get deep into brain tissue, yielding new ways to treat neurological conditions like Huntington’s.

132
132
article thumbnail

Kids with ADHD and the Adderall shortage

STAT

Get your daily dose of health and medicine every weekday with STAT’s free newsletter Morning Rounds.  Sign up here. Good morning, happy Tuesday. I was recently reading an interview with Lucy Dacus — one of my favorite musicians — and was surprised to see longevity science come up. Lucy’s take? “I think it’s silly that these people are trying to live forever, because they’re not going to do it.

140
140

More Trending

article thumbnail

BREAKING: Pharmacy contract negotiations begin for 2024/25 and 2025/26

The Pharmacist

Community Pharmacy Contractual Framework negotiations have now begun for the 2024/25 and 2025/26 funding agreements, the government has announced. The government sent a letter to Community Pharmacy England (CPE) on Monday to signal the start of the negotiations, the Department of Health and Social Care (DHSC) said today. Minister of state for care Stephen Kinnock […] The post BREAKING: Pharmacy contract negotiations begin for 2024/25 and 2025/26 appeared first on The Pharmacist.

article thumbnail

Merck Life Science and DPIIT MoU aims to empower biotech startups

Express Pharma

Overview and rise of the emerging biotech startup space in India. Indias Biotechnology landscape is positioned for rapid growth, underpinned by robust R&D initiatives, a thriving culture of innovation, constant upskilling, and a strong commitment to sustainability. Both private biotech companies and the government have emerged as key enablers, propelling the sector towards achieving a transformative $300 billion bioeconomy milestone by 2030.

100
100
article thumbnail

NPA doubles down on collective action threat as funding talks begin

The Pharmacist

The National Pharmacy Association (NPA) would still recommend that pharmacies reduce their services if the upcoming pharmacy funding offer does not meet its requirements, it has suggested. Negotiations for the 2024/25 and 2025/26 Community Pharmacy Contractual Frameworks began this week, the government announced today. NPA chair Nick Kaye said he welcomed the start of discussions […] The post NPA doubles down on collective action threat as funding talks begin appeared first on The Pharmaci

article thumbnail

Novo Nordisk’s next-generation obesity drug shows promise in early clinical trials

Outsourcing Pharma

Novo Nordisks amycretin shows 22% weight loss over 36 weeks, potentially surpassing Eli Lillys Zepbound. Further trials are planned.

93
article thumbnail

From Diagnosis to Delivery: How AI is Revolutionizing the Patient Experience

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

article thumbnail

Is VR the answer to the great wait?

pharmaphorum

Bring your waiting experience to life with Virtual Reality (VR)! Discover how VR technology is revolutionising the way we pass the time and enhancing customer satisfaction.

88
article thumbnail

Cartesian Therapeutics announces FDA agreement for new trial

Pharma Times

Phase 3 trial of Descartes-08 in myasthenia gravis to start in 1H25

84
article thumbnail

AI in medical imaging company Quibim raises $50m

pharmaphorum

Quibim has raised $50 million in first-round financing to support the rollout of its AI biomarkers for use in the analysis of medical imaging.

86
article thumbnail

Versant invests again in obesity, this time backing Helicore Biopharma

BioPharma Dive

Helicore, which is developing a GIP-blocking antibody, is the fourth obesity drug developer to receive Versant's backing in recent months.

article thumbnail

Why Every Small Business Needs an HCM Solution: A Comprehensive Guide

Managing HR tasks like payroll, compliance, and employee data can overwhelm small businesses. That’s where a Human Capital Management (HCM) solution comes in. Our eBook, Why Every Small Business Needs an HCM Solution: A Comprehensive Guide , shows how an HCM system automates tedious processes, ensuring your business stays compliant and efficient. You’ll learn how to simplify payroll, eliminate costly errors, and empower your employees with self-service tools.

article thumbnail

Sage rejects Biogen takeover and launches review

pharmaphorum

Sage Therapeutics has unanimously rejected Biogen's acquisition offer of around $469 million, saying it "significantly undervalues" the company.

68
article thumbnail

Max Group’s Antara Senior Care partners with Wellbeing Nutrition

Express Pharma

Antara Senior Care, part of the Max Group, has partnered with Wellbeing Nutrition. The collaboration aims to leverage Antaras understanding of senior health needs and Wellbeing Nutritions expertise in creating evidence-based nutraceuticals to co-create products designed specifically for older adults. These products aim to address identified nutritional gaps, offering seniors and their caregivers easy access to research-backed solutions through online and offline channels.

article thumbnail

Veru shares plunge despite positive data in obesity trial

pharmaphorum

Veru's obesity candidate achieved the objective of preserving muscle in people taking weight-loss drug Wegovy, but its share price still fell sharply.

65
article thumbnail

AB2 Bio and Nippon Shinyaku enter Tadekinig alfa licensing deal

Pharmaceutical Technology

AB2 Bio has made an option and licensing agreement with Nippon Shinyaku, granting the latter the option to commercialise Tadekinig alfa.

64
article thumbnail

Best Practices to Streamline Compensation Management: A Foundation for Growth

Speaker: Joe Sharpe and James Carlson

Payroll optimization can be one of the most time-consuming and complex factors of small business management. Yet, organizations that crack the code on streamlining employee compensation often discover innovative avenues for growth. With the right strategies in place, outsourcing and streamlining payroll processes can result in substantial time and resource savings.

article thumbnail

Stopwatch starts on reviews of GSK's long-acting asthma drug

pharmaphorum

Regulators have started reviews of GSK's depemokimab, aiming to become the first drug for asthma that can be dosed twice a year.

64
article thumbnail

FDA Approves Semaglutide to Reduce Kidney Disease, Cardiovascular Death Risk in Adults With Type 2 Diabetes, Chronic Kidney Disease

Pharmacy Times

The new indication for semaglutide adds to the long list of conditions that the GLP-1 receptor agonist has been approved for, and provides a new option for high-risk patients with these chronic conditions.

article thumbnail

Manas AI bags $24.6 million to turbocharge drug discovery

Outsourcing Pharma

Manas AI secures funding led by General Catalyst to scale AI-driven drug discovery, tackling cancer and rare diseases.

62
article thumbnail

Rival radiopharma drug to Novartis’ Lutathera succeeds in trial, ITM says

BioPharma Dive

ITM's lutetium-containing therapy extended progression-free survival versus everolimus in patients with a specific kind of neuroendocrine tumor.

61
article thumbnail

Enhance Healthcare Efficiency With Top Payroll & HCM Services

Running a healthcare facility requires precision and care, not just for patients but also for your staff. Our guide, "A Buyer’s Guide to Payroll & HCM Services," helps healthcare providers choose the best provider. Efficient payroll management ensures timely, accurate payments, critical for maintaining staff morale and trust. Compliance support helps navigate complex healthcare regulations and avoid costly fines.

article thumbnail

Lantheus Announces Agreement to Acquire Evergreen Theragnostics

PharmaTech

The deal is being made for an all-cash price of $250 million, but with an additional $752.5 million available in potential milestone payments.

59
article thumbnail

Amgen and Celltrion Settle Denosumab BPCIA Case

Big Molecule Watch

On January 23, 2025, the District Court for the District of New Jersey entered a Consent Judgment and Injunction in view of a settlement agreement between Amgen and Celltrion resolving the BPCIA litigation regarding Celltrions denosumab biosimilar, CT-P41. Pursuant to the agreement, Celltrion will be enjoined from making, using, selling, or importing CT-P41 into the U.S. market until June 1, 2025.

article thumbnail

Patent Term Extension Calculator: Step-by-Step Expert Guide

Drug Patent Watch

Unlock the Secrets of Patent Term Extension: A Step-by-Step Guide As a pharmaceutical professional, you know how crucial it is to maximize the lifespan of your patented products. Patent term extension (PTE) can be a game-changer, but navigating the complex process can be daunting. That's why we've created a comprehensive guide to help you calculate PTE with confidence.

article thumbnail

ITM’s radiotherapeutic beats out standard-of-care in Phase III trial

Pharmaceutical Technology

the company announced that its Phase III trial examining its gastroenteropancreatic tumour treatment, ITM-11, met its primary endpoint.

59
article thumbnail

Position Your Pharmacy for Expansion

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

article thumbnail

How Dual-Eligible Special Needs Plans Affect Medicaid Spending

Pharmaceutical Commerce

A study explores dual-enrollment in these planscompared to other Medicare Advantage plans impacts North Carolinas Medicaid fee-for-service spending.

59
article thumbnail

Allakos cuts 75% of workforce after chronic hives trial failure 

Pharmaceutical Technology

A year after reducing half of its workforce, Allakos will downsize to just 15 employees as it halts the development of AK006.

59
article thumbnail

Results from Novadip phase 1b/2a trial reveal 88% efficacy

Pharmafile

Novadip Biosciences, a clinical stage biotechnology company with a specialty in regenerative medicine, has announced the results of its 12-month post-surgical visit as part of phase 1b/2a of the NCT05693558 trial. The trial is to monitor the results of an investigational tissue regeneration product from Novadip, NVD003. The product is derived from adipose stem cells […] The post Results from Novadip phase 1b/2a trial reveal 88% efficacy appeared first on Pharmafile.

59
article thumbnail

GLP-1RA developer Metsera targets $289m IPO

Pharmaceutical Technology

Metsera is aiming to put its weight loss drug MET-097i, which boasts of a longer half-life, through Phase III trials.

59
article thumbnail

5 Reasons to Upgrade Your Pharmacy Management Software

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.